230 related articles for article (PubMed ID: 30741378)
1. Thymomatous myasthenia gravis: novel association with HLA DQB1*05:01 and strengthened evidence of high clinical and serological severity.
Massa R; Greco G; Testi M; Rastelli E; Terracciano C; Frezza E; Garibaldi M; Marfia GA; Locatelli F; Mercuri NB; Pompeo E; Antonini G; Andreani M
J Neurol; 2019 Apr; 266(4):982-989. PubMed ID: 30741378
[TBL] [Abstract][Full Text] [Related]
2. Combinations of HLA-DPB1 and HLA-DQB1 alleles determine susceptibility to early-onset myasthenia gravis in Japan.
Horiki T; Inoko H; Moriuchi J; Ichikawa Y; Arimori S
Autoimmunity; 1994; 19(1):49-54. PubMed ID: 7749041
[TBL] [Abstract][Full Text] [Related]
3. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: a population-based survey in the province of Ferrara, northern Italy.
Tola MR; Caniatti LM; Casetta I; Granieri E; Conighi C; Quatrale R; Monetti VC; Paolino E; Govoni V; Pascarella R
Acta Neurol Scand; 1994 Nov; 90(5):318-23. PubMed ID: 7887131
[TBL] [Abstract][Full Text] [Related]
4. Association of HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes with myasthenia gravis and its subgroups in the Iranian population.
Ehsan S; Amirzargar A; Yekaninejad MS; Mahmoudi M; Mehravar S; Moradi B; Nafissi S
J Neurol Sci; 2015 Dec; 359(1-2):335-42. PubMed ID: 26671138
[TBL] [Abstract][Full Text] [Related]
5. Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis.
Spagni G; Todi L; Monte G; Valentini M; Di Sante G; Damato V; Marino M; Evoli A; Lantieri F; Provenzano C
Ann Clin Transl Neurol; 2021 Mar; 8(3):656-665. PubMed ID: 33547763
[TBL] [Abstract][Full Text] [Related]
6. The association of HLA-DQA1*0401 and DQB1*0604 with thymomatous myasthenia gravis in northern Chinese patients.
Yang H; Hao J; Peng X; Simard AR; Zhang M; Xie Y; Wang S
J Neurol Sci; 2012 Jan; 312(1-2):57-61. PubMed ID: 21917268
[TBL] [Abstract][Full Text] [Related]
7. HLA-DRB1*14 and DQB1*05 are associated with Japanese anti-MuSK antibody-positive myasthenia gravis patients.
Kanai T; Uzawa A; Kawaguchi N; Sakamaki T; Yoshiyama Y; Himuro K; Oda F; Kuwabara S
J Neurol Sci; 2016 Apr; 363():116-8. PubMed ID: 27000234
[TBL] [Abstract][Full Text] [Related]
8. HLA-DQB1*05:02, *05:03, and *03:01 alleles as risk factors for myasthenia gravis in a Spanish cohort.
Salvado M; Caro JL; Garcia C; Rudilla F; Zalba-Jadraque L; Lopez E; Sanjuan E; Gamez J; Vidal-Taboada JM
Neurol Sci; 2022 Aug; 43(8):5057-5065. PubMed ID: 35524016
[TBL] [Abstract][Full Text] [Related]
9. In sickness and in health: when myasthenia gravis is a conjugal matter.
Alboini PE; Spagni G; Evoli A
Neurol Sci; 2021 May; 42(5):2099-2101. PubMed ID: 33409825
[TBL] [Abstract][Full Text] [Related]
10. Refractory myasthenia gravis: Characteristics of a portuguese cohort.
Santos E; Bettencourt A; Duarte S; Gabriel D; Oliveira V; da Silva AM; Costa PP; Lopes C; Gonçalves G; da Silva BM; Leite MI
Muscle Nerve; 2019 Aug; 60(2):188-191. PubMed ID: 31050006
[TBL] [Abstract][Full Text] [Related]
11. Acetylcholine receptor antibody titer and HLA-B8 antigen in myasthenia gravis.
Keesey J; Naiem F; Lindstrom J; Roe D; Herrmann C; Walford R
Arch Neurol; 1982 Feb; 39(2):73-7. PubMed ID: 6977352
[TBL] [Abstract][Full Text] [Related]
12. Next-Generation Sequencing Identifies Extended HLA Class I and II Haplotypes Associated With Early-Onset and Late-Onset Myasthenia Gravis in Italian, Norwegian, and Swedish Populations.
Creary LE; Gangavarapu S; Caillier SJ; Cavalcante P; Frangiamore R; Lie BA; Bengtsson M; Harbo HF; Brauner S; Hollenbach JA; Oksenberg JR; Bernasconi P; Maniaol AH; Hammarström L; Mantegazza R; Fernández-Viña MA
Front Immunol; 2021; 12():667336. PubMed ID: 34163474
[TBL] [Abstract][Full Text] [Related]
13. Association of HLA-DRB1∗14, -DRB1∗16 and -DQB1∗05 with MuSK-myasthenia gravis in patients from Turkey.
Alahgholi-Hajibehzad M; Yilmaz V; Gülsen-Parman Y; Aysal F; Oflazer P; Deymeer F; Saruhan-Direskeneli G
Hum Immunol; 2013 Dec; 74(12):1633-5. PubMed ID: 23993985
[TBL] [Abstract][Full Text] [Related]
14. Thymomatous myasthenia gravis: 10-year experience of a single center.
Chen J; Shang W; Chen Y; Li Y; Huang X; Su C; Zhu K; Zhang J; Liu W; Feng H
Acta Neurol Scand; 2021 Jan; 143(1):96-102. PubMed ID: 32762063
[TBL] [Abstract][Full Text] [Related]
15. Do acetylcholine receptor and striated muscle antibodies predict the presence of thymoma in patients with myasthenia gravis?
Choi Decroos E; Hobson-Webb LD; Juel VC; Massey JM; Sanders DB
Muscle Nerve; 2014 Jan; 49(1):30-4. PubMed ID: 23625360
[TBL] [Abstract][Full Text] [Related]
16. Human Leucocyte Antigen B50 Is Associated with Conversion to Generalized Myasthenia Gravis in Patients with Pure Ocular Onset.
Tiftikcioglu BI; Uludag IF; Zorlu Y; Pirim İ; Sener U; Tokucoglu F; Korucuk M
Med Princ Pract; 2017; 26(1):71-77. PubMed ID: 27802446
[TBL] [Abstract][Full Text] [Related]
17. HLA class II and class I polymorphism in Venezuelan patients with myasthenia gravis.
Fernández-Mestre MT; Vargas V; Montagnani S; Cotúa M; Ogando V; Layrisse Z
Hum Immunol; 2004 Jan; 65(1):54-9. PubMed ID: 14700596
[TBL] [Abstract][Full Text] [Related]
18. Myasthenia gravis patients with thymus hyperplasia and myasthenia gravis patients with thymoma display different HLA associations.
Spurkland A; Gilhus NE; Rønningen KS; Aarli JA; Vartdal F
Tissue Antigens; 1991 Feb; 37(2):90-3. PubMed ID: 2057938
[TBL] [Abstract][Full Text] [Related]
19. High frequency of DQB1*05 and absolute absence of DRB1*13 in muscle-specific tyrosine kinase positive myasthenia gravis.
Nikolic AV; Andric ZP; Simonovic RB; Rakocevic Stojanovic VM; Basta IZ; Bojic SD; Lavrnic DV
Eur J Neurol; 2015 Jan; 22(1):59-63. PubMed ID: 25070808
[TBL] [Abstract][Full Text] [Related]
20. Association with HLA DQ of early onset myasthenia gravis in Southeast Texas region of the United States.
Deitiker PR; Oshima M; Smith RG; Mosier D; Atassi MZ
Int J Immunogenet; 2011 Feb; 38(1):55-62. PubMed ID: 21108743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
